Race Contacts and Interracial Relations: Lectures on the Theory and Practice of Race (Moorland-Spingarn Series) by Locke, Alain Leroy, Stewart, Jeffrey C.(December 1, 1992) Paperback
Trius Therapeutics, Inc. - San Diego CA, US Jeffrey B. Locke - La Jolla CA, US Karen Joy Shaw - Poway CA, US Philippe G. Prokocimer - Cardiff by the Sea CA, US
Assignee:
TRIUS THERAPEUTICS, INC. - San Diego CA
International Classification:
A61K 38/12 A61P 29/00 A61P 31/04
US Classification:
514 26, 514 29, 514 27
Abstract:
A therapeutic combination comprises an antibacterially effective amount of daptomycin, and an amount of protein synthesis inhibitor antibiotic effective to prevent the development of daptomycin non-susceptibility in bacteria. Related combination therapies and methods are also included.
Therapeutic Combination Of Daptomycin And Protein Synthesis Inhibitor Antibiotic, And Methods Of Use
A therapeutic combination comprises an antibacterially effective amount of daptomycin, and an amount of protein synthesis inhibitor antibiotic effective to prevent the development of daptomycin non-susceptibility in bacteria. Related combination therapies and methods are also included.
Single Dose Methods For Preventing And Treating Fungal Infections
- San Diego CA, US Paul DARUWALA - Del Mar CA, US Jeffrey B. LOCKE - La Jolla CA, US Voon ONG - San Diego CA, US Taylor SANDISON - Encinitas CA, US
International Classification:
A61K 38/17 A61P 31/10 A61K 9/00 A61L 29/08
Abstract:
Provided herein are methods for treating, mitigating, or preventing fungal infections or related conditions thereto in a human subject in need thereof. The methods include the administration of a single dose of a pharmaceutical composition comprising or consisting of CD101 and any pharmaceutically acceptable excipients, wherein the single dose treatment substantially reduces or eliminates the fungal infection.
Dosing Regimens For Treatment Of Fungal Infections
- San Diego CA, US Paul DARUWALA - Del Mar CA, US Jeffrey Brian LOCKE - La Jolla CA, US Voon ONG - San Diego CA, US Taylor SANDISON - Encinitas CA, US Dirk THYE - San Diego CA, US
International Classification:
A61K 38/12 A61K 9/00 A61P 31/10 G01N 33/569
Abstract:
The disclosure features pharmaceutical compositions, methods, and kits featuring dosing regimens and CD101, or a pharmaceutical acceptable salt or neutral form thereof (e.g., CD101 acetate).
- San Diego CA, US Kenneth BARTIZAL - La Jolla CA, US Jeffrey Brian LOCKE - La Jolla CA, US Voon ONG - San Diego CA, US Taylor SANDISON - Encinitas CA, US Dirk THYE - San Diego CA, US David S. PERLIN - New York NY, US
International Classification:
A61K 38/12 A61P 31/10 A61K 9/00
Abstract:
The disclosure relates to methods of treating a fungal infection in a subject by administering to the subject a salt of Compound 1, or a neutral form thereof. The methods of the disclosure can be useful in subjects suffering from treatment resistant infections, useful in subjects who have previously failed treatment with an anti-fungal therapy, and useful for suppressing the emergence of resistant strains in infected subjects.
Normally, people properly served subpoenas who dont appear can face court-ordered charges of their own, but its possible that the judge in the trial,Jeffrey Locke, agreed with Baez to simply proceedwithout Belichick. It is also possible that lawyers for the coach came to an undisclosed arrangeme